Prometheus Laboratories (@prometheuslab) header
Prometheus Laboratories (@prometheuslab) profile picture

A leader of precision healthcare in gastroenterology, offering novel diagnostic testing services to help physicians provide the highest level of patient care

San Diego, CA
Joined April 2021
Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)Photo by Prometheus Laboratories (@prometheuslab)
Prometheus Laboratories retweeted
Correction: Infant less than mom!
Risankizumab, IgG1, has lower than expected placental transfer rates with infant > mom. @MLongMD @PIANOIBD @UCSFHospitals Low Placental Transfer Rates of Risankizumab Among Pregnant Women With Inflammatory Bowel Disease academic.oup.com/ibdjournal/…
2
11
1,653
Prometheus Laboratories retweeted
Lawrence et al compared standard induction with #IFX vs optimized induction in #children with #IBD finding that optimized induction was associated with ⬆️ odds of achieving long-term clinical remission. https://nitter.cf/t.co/oaIjtsfOCS
8
6
Prometheus Laboratories retweeted
Proactive infliximab optimization during induction guided by a pharmacokinetics dashboard improves IFX durability and immunogenicity. <8% of pts were ADA ➕ by end of induction & most ADAs were transient. https://nitter.cf/t.co/Qzeibyunp8
4
23
#ACG2021 🔺Is the risk of anti-drug antibodies (ADA) inevitable in + HLA-DQA1*05 #PANTS? @pedsIBDdoc shows that 💎Achieving target drug level at 🔑induction🔑 can overcome HLA-risk of ADA 💎Proactive #TDM at induction can replace need for combo Rx w TNFi to prevent ADA
1
8
27
Prometheus Laboratories retweeted
⬆️ level is associated with ⬆️ response
1
1
1
Prometheus Laboratories retweeted
More data supporting #tdm in #ibd for tnf antagonists and ustekinumab onlinelibrary.wiley.com/doi/… @waqqasafif @IBD_FloMD @guthealthmd @DCharabaty
5
20
Prometheus Laboratories retweeted
Serum Ustekinumab Concentrations are Associated with Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index | Crohn's & Colitis 360 | Oxford Academic ⁦@guthealthmd⁩ ⁦@waqqasafif⁩ academic.oup.com/crohnscolit…
13
27